Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | %Female (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Topics in antiviral medicine | journal | 2.974 Q1 | 46 | 20 | 59 | 72 | 357 | 58 | 7.62 | 3.60 | 30.30 | |
52 | Journal of Biopharmaceutical Statistics | journal | 1.064 Q1 | 56 | 85 | 246 | 1783 | 354 | 224 | 1.13 | 20.98 | 30.43 | |
53 | Biologicals | journal | 0.602 Q2 | 66 | 113 | 181 | 3214 | 329 | 167 | 1.89 | 28.44 | 38.40 | |
54 | Microbial Drug Resistance | journal | 1.054 Q1 | 78 | 48 | 138 | 1544 | 307 | 138 | 2.29 | 32.17 | 46.84 | |
55 | Reading Teacher | journal | 0.721 Q2 | 60 | 85 | 244 | 1516 | 208 | 242 | 0.83 | 17.84 | 80.15 | |
56 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.896 Q2 | 70 | 35 | 104 | 1236 | 190 | 103 | 1.84 | 35.31 | 24.77 | |
57 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.552 Q1 | 82 | 11 | 38 | 1827 | 176 | 38 | 3.84 | 166.09 | 41.38 | |
58 | CNS Drug Reviews | journal | 1.699 Q1 | 64 | 0 | 26 | 0 | 154 | 26 | 0.00 | 0.00 | 0.00 | |
59 | Drug and Chemical Toxicology | journal | 0.340 Q3 | 54 | 53 | 125 | 1796 | 142 | 125 | 1.06 | 33.89 | 40.35 | |
60 | Journal of Experimental Therapeutics and Oncology | journal | 0.699 Q2 | 40 | 17 | 71 | 546 | 138 | 70 | 2.15 | 32.12 | 36.92 | |
61 | Cardiovascular Drug Reviews | journal | 1.673 Q1 | 54 | 0 | 25 | 0 | 134 | 24 | 0.00 | 0.00 | 0.00 | |
62 | Advances in Pharmacology | journal | 1.013 Q2 | 86 | 42 | 45 | 4899 | 108 | 38 | 1.55 | 116.64 | 0.00 | |
63 | Pharmaceutical Chemistry Journal | journal | 0.135 Q4 | 39 | 123 | 491 | 1973 | 92 | 489 | 0.15 | 16.04 | 56.85 | |
64 | Medical Letter on Drugs and Therapeutics | journal | 0.185 Q3 | 22 | 117 | 232 | 441 | 82 | 225 | 0.35 | 3.77 | 45.16 | |
65 | Hospital Pharmacy | journal | 0.141 Q4 | 28 | 157 | 444 | 1744 | 76 | 378 | 0.12 | 11.11 | 42.03 | |
66 | International Journal of Medicinal Mushrooms | journal | 0.234 Q3 | 41 | 44 | 108 | 1245 | 68 | 107 | 0.66 | 28.30 | 40.51 | |
67 | Current Cardiovascular Risk Reports | journal | 0.210 Q3 | 34 | 65 | 221 | 2782 | 63 | 213 | 0.32 | 42.80 | 44.22 | |
68 | Food and Drug Law Journal | journal | 0.329 Q3 | 23 | 35 | 117 | 7167 | 62 | 117 | 0.57 | 204.77 | 56.00 | |
69 | Current Therapeutic Research | journal | 0.171 Q3 | 46 | 33 | 122 | 951 | 57 | 119 | 0.56 | 28.82 | 27.45 | |
70 | Metal-Based Drugs | journal | 0.395 Q3 | 40 | 4 | 26 | 266 | 55 | 24 | 2.48 | 66.50 | 36.36 | |
71 | Proceedings of the Western Pharmacology Society | journal | 0.182 Q3 | 25 | 13 | 98 | 191 | 50 | 98 | 0.28 | 14.69 | 32.14 | |
72 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.228 Q3 | 34 | 21 | 93 | 455 | 47 | 93 | 0.52 | 21.67 | 27.78 | |
73 | Supportive Cancer Therapy | journal | 0.410 Q3 | 15 | 0 | 28 | 0 | 40 | 26 | 0.00 | 0.00 | 0.00 | |
74 | Pharmacopeial Forum (discontinued) | journal | 0.235 Q3 | 20 | 25 | 47 | 202 | 37 | 47 | 0.85 | 8.08 | 25.00 | |
75 | U.S. Pharmacist | trade journal | 0.115 Q4 | 12 | 136 | 463 | 2380 | 37 | 437 | 0.08 | 17.50 | 63.43 | |
76 | Journal of Herbal Pharmacotherapy | journal | 0.261 Q3 | 33 | 0 | 32 | 0 | 33 | 31 | 0.00 | 0.00 | 0.00 | |
77 | Journal of Applied Research | journal | 0.195 Q3 | 23 | 16 | 73 | 415 | 24 | 67 | 0.42 | 25.94 | 28.57 | |
78 | Current Protocols in Pharmacology | journal | 0.177 Q3 | 39 | 22 | 55 | 567 | 17 | 49 | 0.40 | 25.77 | 30.61 | |
79 | Pharmacy Times | trade journal | 0.106 Q4 | 8 | 196 | 674 | 1009 | 16 | 596 | 0.02 | 5.15 | 54.41 | |
80 | Clinical Research and Regulatory Affairs | journal | 0.262 Q3 | 18 | 17 | 36 | 409 | 15 | 35 | 0.43 | 24.06 | 26.42 | |
81 | Cancer Therapy | journal | 0.227 Q3 | 9 | 18 | 47 | 668 | 13 | 47 | 0.28 | 37.11 | 19.70 | |
82 | National Toxicology Program technical report series | journal | 0.184 | 22 | 13 | 15 | 0 | 12 | 15 | 1.22 | 0.00 | 0.00 | |
83 | Internet Journal of Pharmacology | journal | 0.118 Q4 | 9 | 24 | 41 | 652 | 11 | 41 | 0.27 | 27.17 | 36.67 | |
84 | Drug Topics | journal | 0.101 Q4 | 8 | 218 | 796 | 36 | 7 | 590 | 0.01 | 0.17 | 28.57 | |
85 | Adverse Drug Reaction Bulletin | journal | 0.113 Q4 | 8 | 6 | 18 | 267 | 5 | 18 | 0.08 | 44.50 | 50.00 | |
86 | Journal of Pharmaceutical Finance, Economics and Policy | journal | 0.160 Q4 | 8 | 0 | 40 | 0 | 5 | 31 | 0.13 | 0.00 | 0.00 | |
87 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.102 | 6 | 0 | 70 | 0 | 3 | 69 | 0.04 | 0.00 | 0.00 | |
88 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.102 Q4 | 29 | 10 | 14 | 618 | 2 | 3 | 0.13 | 61.80 | 0.00 | |
89 | Psychopharm Review | trade journal | 0.172 Q3 | 5 | 12 | 12 | 554 | 2 | 12 | 0.17 | 46.17 | 17.65 | |
90 | Neuropsychopharmacology Reports | journal | 22 | 2 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | ||
91 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.101 Q4 | 40 | 0 | 17 | 0 | 0 | 17 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®